Analysts Lower Waldencast Price Targets Amid Challenging Sales

Several analysts have lowered price targets for Waldencast (NASDAQ: WALD) amid challenging market conditions and mixed financial results. Canaccord Genuity reduced its price target from $6.00 to $5.00, maintaining a Buy rating despite the company's first-quarter sales decline and weaker-than-expected adjusted EBITDA, which contrasted with strong gross profit margins. Telsey Advisory Group also cut its price target from $5.00 to $4.00 but kept an Outperform rating, citing risks from the global macroeconomic environment and difficulties in the Milk Makeup brand's performance alongside supply chain issues for Obagi. The stock has declined over 40% year-to-date and is trading well below its 52-week high, though management remains optimistic about meeting full-year 2025 sales and EBITDA guidance driven by new product launches and expanded distribution. Analysts highlight Waldencast’s strong gross margins and brand potential despite short-term operational challenges. Overall, the consensus reflects cautious optimism about Waldencast's long-term growth prospects amid near-term headwinds.